dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Figlioli, Gisella |
dc.contributor.author | Bogliolo, Massimo |
dc.contributor.author | Catucci, Irene |
dc.contributor.author | Caleca, Laura |
dc.contributor.author | Lasheras, Sandra Viz |
dc.contributor.author | Pujol, Roser |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Diez Gibert, Orland |
dc.date.accessioned | 2021-03-23T14:42:57Z |
dc.date.available | 2021-03-23T14:42:57Z |
dc.date.issued | 2019-11-01 |
dc.identifier.citation | Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. npj Breast Cancer. 2019 Dec 1;5(1):1–14. |
dc.identifier.issn | 2374-4677 |
dc.identifier.uri | https://hdl.handle.net/11351/5790 |
dc.description | Càncer de mama; Genètica del càncer |
dc.description.sponsorship | Peterlongo laboratory is supported by Associazione Italiana Ricerca sul Cancro (AIRC; IG2015 no.16732) to P. Peterlongo and by a fellowship from Fondazione Umberto Veronesi to G. Figlioli. Surrallés laboratory is supported by the ICREA-Academia program, the Spanish Ministry of Health (projects FANCOSTEM and FANCOLEN), the Spanish Ministry of Economy and Competiveness (projects CB06/07/0023 and RTI2018-098419-B-I00), the European Commission (EUROFANCOLEN project HEALTH-F5-2012-305421 and P-SPHERE COFUND project), the Fanconi Anemia Research Fund Inc, and the “Fondo Europeo de Desarrollo Regional, una manera de hacer Europa” (FEDER). CIBERER is an initiative of the Instituto de Salud Carlos III, Spain. |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation.ispartofseries | npj Breast Cancer;5 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Càncer - Aspectes genètics |
dc.subject.mesh | Triple Negative Breast Neoplasms |
dc.subject.mesh | /genetics |
dc.title | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41523-019-0127-5 |
dc.subject.decs | neoplasias de mama triple negativos |
dc.subject.decs | /genética |
dc.relation.publishversion | https://www.nature.com/articles/s41523-019-0127-5 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Figlioli G, Catucci I] IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy. [Bogliolo M, Pujol R] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain. Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain. [Caleca L] Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy. [Lasheras SV] Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. [Balmaña J] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Diez O] Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Genètica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 31700994 |
dc.identifier.wos | 000493912600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-098419-B-I00 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/FP7/HEALTH-F5-2012-305421 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |